The store will not work correctly when cookies are disabled.
2-[5-Amino-3-(4-chlorophenyl)pyrazol-1-yl]-3-benzylquinoxaline
ID: ALA3621364
PubChem CID: 101909244
Max Phase: Preclinical
Molecular Formula: C24H18ClN5
Molecular Weight: 411.90
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1cc(-c2ccc(Cl)cc2)nn1-c1nc2ccccc2nc1Cc1ccccc1
Standard InChI: InChI=1S/C24H18ClN5/c25-18-12-10-17(11-13-18)21-15-23(26)30(29-21)24-22(14-16-6-2-1-3-7-16)27-19-8-4-5-9-20(19)28-24/h1-13,15H,14,26H2
Standard InChI Key: JWHWJCGVBBDUFE-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
-1.2964 1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9091 -1.5019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9067 -3.0027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2030 -3.7575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1976 -5.2575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8958 -6.0028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5995 -5.2481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6050 -3.7481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9086 1.5029 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.0363 2.9847 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.5014 3.3065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2601 2.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2640 0.8910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1025 4.6816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3079 5.9479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.0105 7.2733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5095 7.3275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.3060 6.0564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.6034 4.7311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.0715 8.3877 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-5.5144 -0.2825 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
1 10 1 0
5 10 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
12 17 2 0
3 11 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
18 22 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
23 28 2 0
26 29 1 0
20 23 1 0
22 30 1 0
2 18 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 411.90 | Molecular Weight (Monoisotopic): 411.1251 | AlogP: 5.31 | #Rotatable Bonds: 4 |
Polar Surface Area: 69.62 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 2.63 | CX LogP: 5.84 | CX LogD: 5.84 |
Aromatic Rings: 5 | Heavy Atoms: 30 | QED Weighted: 0.43 | Np Likeness Score: -1.16 |
References
1. Issa DAE, Habib NS, Abdel Wahab AE. (2015) Design, synthesis and biological evaluation of novel 1,2,4-triazolo and 1,2,4-triazino[4,3-a]quinoxalines as potential anticancer and antimicrobial agents, 6 (1): [10.1039/C4MD00257A] |